Fujirebio Diagnostics Receives FDA Clearance for the HE4 EIA Assay for the monitoring of patients with ovarian cancer
Malvern, PA, USA - June 19, 2008 - The HE4 assay is CE marked in Europe and will be available to US-based physicians in July.
Malvern, PA, USA - June 19, 2008 - The HE4 assay is CE marked in Europe and will be available to US-based physicians in July.
Choose your country or region